Skip to main content
. 2022 Oct 3;12(10):1417. doi: 10.3390/biom12101417

Figure 2.

Figure 2

Number of pathogenic/likely pathogenic (P/LP) variants and VUSs according to ACMG guidelines, identified in the patients analyzed using (A) first-level and (B) enlarged panels and divided by main and uncommon genes.